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Objective: To evaluate the effectiveness of patient decision aids (PtDA) compared to usual education on
appropriate and timely access to total joint arthroplasty in patients with osteoarthritis.
Method: A randomized controlled trial (RCT) with patients undergoing orthopedic screening. Control
and intervention arms received usual education; intervention arm also received a PtDA and a surgeon
preference report. Wait times (primary outcome) were described using stratiﬁed KaplaneMeier survival
curves with patients censored at the time of death or loss to follow-up, and multivariable Cox propor-
tional hazards regression. Secondary outcomes were compared using stratiﬁed Cochran-Mantel-
Haenszel chi-squared tests.
Results: 343 patients were randomized to intervention (n ¼ 174) or control (n ¼ 169). The typical patient
was 66 years old, retired, living with someone, and 51% had high school education or less. The inter-
vention was associated with a trend towards reduction in wait time (hazard ratio (HR) 1.25, 95% con-
ﬁdence interval (CI) 0.99e1.60, P ¼ 0.0653). Median wait times were 3 weeks shorter in intervention
than in control at the community site with no difference at the academic site. Good decision quality was
reached by 56.1% intervention and 44.5% control (Relative risk (RR) 1.25; 95% CI 1.00e1.56, P ¼ 0.050).
Surgery rates were 73.2% intervention and 80.5% controls (RR 0.91: 95% CI 0.81e1.03) with 12 inter-
vention (7.3%) and eight control participants (4.9%) returning to have surgery within 2 years (P ¼ 0.791).
Conclusion: Compared to controls, decision aid recipients had shorter wait times at one site, fewer
surgeries, and were more likely to reach good decision quality, but overall effect was not statistically
signiﬁcant.
Trials registration: The full trial protocol is available at ClinicalTrials.Gov (NCT00911638).
© 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.D. Stacey, School of Nursing,
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There is growing demand for hip and knee arthroplasty with
increased osteoarthritis, obesity, and older adults' desire to main-
tain a high level of physical activity1. Surgical demand can be
addressed by considering the need for more resources while
ensuring appropriate use of joint arthroplasty. Patients are appro-
priate for joint arthroplasty when pain and functional limitations
interfere with their quality of life despite use of conservative
treatment2,3. Patient preferences are another important element of
appropriateness3,4. However, patient preferences are oftentd. All rights reserved.
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quently inﬂuence satisfaction with joint arthroplasty5e7. In fact,
many patients agree to surgical referral for management of joint
pain without adequate knowledge or consideration of their
options8e10. Interventions are required to realign patients' expec-
tations and ensure patient preferences inform appropriate use of
joint arthroplasty.
Patient decision aids (PtDA) communicate evidence on treat-
ment options in patient-friendly terms and guide patients through
a decision making process11. Three randomized controlled trials
(RCT) have evaluated PtDA effects on patients with osteoarthritis
considering hip and/or knee arthroplasty12e14. All trials used PtDAs
(e.g., digital video-disc and booklet) produced by the Informed
Medical Decisions Foundation and one trial12 included a health
coach to help patients navigate the decision making process.
Compared to controls, patients in the PtDA group experienced less
decisional conﬂict, felt more informed, and were better prepared
for the surgical consultation. As well, orthopedic surgeons in the
trial with health coaches reported greater satisfaction, consultation
efﬁciency, and patients asked more relevant questions12. Trials of
PtDAs for other treatment decisions have increased realistic ex-
pectations and achieved choices based on informed patients'
preferences11.
PtDAs may also improve timely access to treatment of osteoar-
thritis. For example, using PtDAs may identify patients who never
intend to have surgery by helping them understand their treatment
options and clarify their informed preferences before the surgical
referral. As well, patients exposed to PtDAs prior to surgical
consultation may be better prepared, making the visit more efﬁ-
cient by optimizing the surgeons' time and the consent process12,15.
PtDAs can reduce patients' decisional conﬂict and those with less
decisional conﬂict are less likely to change their mind or delay
decision making16,17.
In preparation for this study, we conducted a pilot RCT14.
Compared to usual care, patients given the PtDA were more
knowledgeable (71% vs 47%; P < 0.001) and a higher proportion
achieved good decision quality (56% vs 25%; P < 0.001). Given that
13% of patients were on the surgical wait list after 1 year, we
determined that subsequent studies would require longer follow-
up to evaluate the impact of PtDAs on wait time outcomes.
The overall aim of this study was to evaluate the effectiveness of
PtDAs compared to usual education on appropriate and timely ac-
cess to total joint arthroplasty in patients with osteoarthritis. We
hypothesized that PtDAs would inﬂuence the quality of decisions
and timeliness of joint arthroplasty for thosewho prefer it and have
osteoarthritis severe enough to require it.
Method
Design
A prospective multicenter, parallel group, single blind, two-arm
RCT with equal randomization (1:1), was conducted based on the
Ottawa Decision Support Framework18. This framework asserts that
decision support tailored to unresolved decisional needs (i.e.,
inadequate knowledge, unrealistic expectations, unclear values,
inadequate support) improves decision quality deﬁned as informed
choice based on patient preferences. Patients whose decisional
needs are unresolved are more likely to delay decisions, change
their mind, feel regret, express dissatisfaction, and blame the
practitioner for poor outcomes16,17. In compliance with the Helsinki
Declaration, participating hospitals' Research Ethic Boards
approved this study. We made two changes from the trials registry
protocol to the current study: (1) follow-up data collection was
expanded to include email; and (2) decisional regret was notmeasured due to surgical wait time variability. Cost-effectiveness
and quality of life will be reported elsewhere.
Setting
Patients were recruited from two orthopedic screening clinics in
Eastern Ontario, Canada (i.e., academic teaching hospital and large
community hospital). Patients were asked to self-report pain,
stiffness, and function using the validated Western Ontario and
McMaster Universities Osteoarthritis (WOMAC) Index19. A sports
medicine physician (site 1), advanced practice physiotherapist (site
2), or nurse practitioner (site 2) assessed surgical candidacy using
the 7-item Western Canada Wait List Hip Knee Priority Tool map-
ped onto three guideline criteria indicating minimally appropriate
for considering joint arthroplasty (moderate to severe pain, mod-
erate to severe functional limitations, abnormal radiographic
ﬁndings)20. At both clinics, appropriate patients were given stan-
dard hospital information on joint replacement surgery (i.e.,
preparation for surgery, recovery after surgery, discharge plans).
This standard written information did not include surgical beneﬁts
and harms, alternative options, or anything that could support
decision making. Appropriate patients were then referred to an
orthopedic surgeon (7 surgeons at site 1; 6 at site 2).
Participants
Eligible adults aged 18 or over had moderate or severe hip or
knee radiographic osteoarthritis and were determined at the or-
thopedic screening clinic to be appropriate for surgical consultation
about joint arthroplasty8. Patients with inﬂammatory arthritis,
previous joint arthroplasty surgical consultation, or osteotomy
were ineligible. In addition, patients were excluded if they had non-
corrected hearing or visual impairment, were unable to read or
understand English, or did not have access to a television with a
VCR or DVD player.
Interventions
The intervention group received standard patient education, a
PtDA and a preference report for the surgeon. The PtDAs were titled
Treatment choices for hip osteoarthritis and Treatment choices for
knee osteoarthritis; 50-min videos and booklets produced by the
Informed Medical Decisions Foundation. Both PtDAs met the In-
ternational Patient Decision Aid Standards criteria by making
explicit the decision and providing evidence-based information on
treatment options, beneﬁts and risks, and related probabilities21.
They included patients' testimonials (e.g., describing treatment
options, their decision making process experiences, and outcomes)
that help patients clarify their values associated with option out-
comes. Additional details are available at https://decisionaid.ohri.
ca/cochinvent.php. Patients' knowledge, values, preferred treat-
ment choice, and decisional conﬂict were assessed using a ques-
tionnaire formatted as a user-friendly leaﬂet. These ﬁndings were
combined with patients' clinical assessment results to create a one-
page preference report for the surgeon14.
The control intervention consisted of standard patient educa-
tion and surgeons received a half-page summary of patients' clin-
ical assessment ﬁndings only.
Procedures
Eligible patients met with a research assistant who obtained
written consent, demographic information and the WOMAC Index
and Hip and Knee Replacement Priority Criteria Tool results19,20.
These baseline data were used to populate the surgeon's clinical
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ware was used to obtain randomized allocation. Patients were
stratiﬁed by affected joint (hip/knee) and site. They were then
randomized to the control or intervention group. The allocation
schedule was computer-generated centrally by a statistician, using
block randomization, with randomly varying block lengths of 4, 6,
or 8. To minimize bias after allocation, patients reviewed the in-
formation (i.e., PtDA plus usual education or usual education only)
at home, were not informed of the other intervention, and did not
have contact with orthopedic screening clinic practitioners during
the 2 weeks post clinic visit when measures were collected.
Although the research assistant was not blinded to group alloca-
tion, the primary outcome was objective and used clinic data.
Within 2 weeks of recruitment, the research assistant tele-
phoned participants to obtain their answers to the hip-knee oste-
oarthritis decision quality, decisional conﬂict, preferred treatment
option, and preparation for decision making instruments. This in-
formation was added to the surgeon's clinical summary report to
create a preference report for surgeons14. Participants were con-
tacted by telephone 6 months after recruitment to administer the
decisional conﬂict questionnaire and determine whether they had
seen the orthopedic surgeon, and if so, whether they had chosen
surgery or alternative non-surgical options. Participants were
contacted again at 12, 18, and 24 months to determine if they had a
surgical consultation and whether they had chosen surgery or non-
surgical options. Surgeon consultation and surgery dates were
collected from the clinic records.
Sample size
The sample size was calculated for total wait times and
informed by our pilot study14. We determined that 155 patients
were needed per group, followed for 2 years, to detect a clinically
important difference of 8 weeks in mean total wait times using a
two-sided t-test at the 5% level of signiﬁcance with 80% power,
assuming a common standard deviation (SD) of 25 weeks. The
clinically important difference of 8 weeks was chosen after dis-
cussion with clinical experts on the research team. To account for
10% loss to follow-up, our target enrolment was 173 patients per
group.
Outcomes
The primary outcome was the wait times calculated by the
number of days from screening that determined appropriate for
surgical consultation to implementation of the deﬁnitive choice
(i.e., surgery date or date of decision to decline the surgery, either
explicitly stated or based on the date the appointment was
cancelled without rebooking). Once patients have surgery or decide
not to have surgery, they are removed from the wait list. National
joint arthroplasty wait time benchmark is 26 weeks from surgical
consultation to surgery22,23.
Secondary outcomes, based on the International Patient Deci-
sion Aid Standards, were good decision quality, realistic expecta-
tion of outcomes, surgical rates within 2 years, and perceptions of
the decision making process21. Good decision quality was deﬁned
by a patient score >66% on the knowledge test and if their predicted
probability of surgery based on values corresponded with their
actual choice14. Realistic expectations were the proportion of pa-
tients who correctly indicated the chances of an outcome in a sub-
set of knowledge test questions. Surgical rates were determined by
the proportion of patients who proceeded to surgery within 2
years, based on clinic data. For patients who chose non-surgical
options, return to the waitlist was measured. Patients' percep-
tions of the quality of the decision making process were measuredusing the Decisional Conﬂict and Preparation for Decision Making
Scales24e26.Outcome instruments
Hip-knee osteoarthritis decision quality instrumentwas used
to assess patients' decision quality with multiple-choice questions
examining knowledge (18 items) and values (7 items)27. This in-
strument is reproducible and demonstrates discriminant, content,
and predictive validity. The 5-item screener knowledge score was
used in the decision quality calculation and a sub-set of three
questions for determining realistic expectations of outcomes. These
5-items measure knowledge relevant to surgery and have high
reproducibility with total knowledge score (Pearson correlation
coefﬁcients >0.92, P < 0.001).
Decisional conﬂict scale, measured using the SURE tool
version, assessed patients' perception of feeling sure, informed,
supported, and clear about what mattered most25. The SURE tool
showed adequate internal consistency (KudereRichardson 20 co-
efﬁcient of 0.7) and was signiﬁcantly correlated with the original
Decision Conﬂict Scale26.
For Preparation for decision making scale, 4 of the original 10
items were used given their relevance to International Patient
Decision Aid Standards for evaluating decision processes21. These
items discriminated between patients who were and were not
prepared for decisionmaking. Discrimination values for these items
were excellent, ranging from 2.1 to 3.424.Data management and statistical methods
All data were analyzed using SAS v. 9.3. The primary outcome
(wait time from screening to implementation of the deﬁnitive
choice) was described using KaplaneMeier survival curves for each
site; the median wait times with 95% conﬁdence intervals (CIs)
were calculated for each group. To assess the statistical signiﬁcance
of the PtDA on the primary outcome, we used multivariable Cox
proportional hazards regression controlling for site and joint (hip or
knee). Results were expressed as hazard ratios (HRs) with 95% CI.
The proportional hazards assumption was tested using martingale
residuals. Patients were censored at the end of the study, at the
time of death, or loss to follow-up.
Dichotomous secondary outcomes (e.g., proportions reaching
good decision quality, surgery rates, congruence between patients'
choice and their values, SURE test) were compared between groups
using Cochran-Mantel-Haenszel chi-squared tests, controlling for
site. The BresloweDay test for homogeneity was used to examine
heterogeneity across sites. The relative difference in proportions
between the intervention and control arms was calculated as
Relative Risk (RR) with 95% CIs; if important qualitative interaction
was detected, separate RR estimates were calculated for each site.
The predicted probability of surgery, used to calculate good
decision quality and congruence between patients' choice and
values, was calculated for each patient using a logistic regression
equation. The equation was derived using the approach in14: In
particular, stepwise backwards elimination was used to identify
independent variables from the seven values items on the Hip-
Knee Osteoarthritis Decision Quality Instrument. The predicted
probability of surgery was calculated as ½1þ expðSÞ1 where S ¼
0:5327þ ð0:1569 ValueQ11Þ þ ð0:1115 ValueQ14Þ þ
ð0:2843 ValueQ17Þ where Q11 was avoiding surgery, Q14 was
avoiding prescription pain medication, and Q17 was avoid pain
remaining the same. Good decision quality was then calculated as a
dichotomous indicator, deﬁned as scoring >66% on the knowledge
test and having a predicted probability 0.5 for a patient with
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surgery27.
The mean knowledge test scores and Preparation for Decision
Making were compared between the two groups using the two-
sample t-test. Fisher's exact test was used in the case of small ex-
pected number of events. Tests were conducted at the two-sided 5%
level of signiﬁcance.
Results
Participant ﬂow
Between May 2008 and October 2009, 343 participants were
randomized to the intervention (n ¼ 174) or usual care (n ¼ 169)
and followed for 2 years (Fig. 1). Common reasons for ineligibility
were mild osteoarthritis, previous arthroplasty, and language bar-
riers. Baseline data were available for only 167 in each arm and
ﬁndings were analyzed based on participants' original assigned
groups. The typical participant was 66 years old, retired, living with
someone else, and 51% had high school education or less (Table I).
Participants were considering knee arthroplasty (n ¼ 242) or hip
arthroplasty (n ¼ 92). There was no statistically signiﬁcant baseline
differences between the groups based on demographic character-
istics or osteoarthritis severity that were self-reported or practi-
tioner-reported.
At the end of the 2-year follow-up (October 2011), there were
165 intervention group participants and 163 controls included in
the primary outcome analysis. In the intervention group, two par-
ticipants were missing wait time data and ﬁve were ineligible
because they were awaiting MRI results for diagnosis, had a
meniscal tear, underwent osteotomy, did not have osteoarthritis, or
VCRwas broken. In the control group, three weremissing wait time
data, one was having hip resurfacing not total hip arthroplasty, and
two were ineligible because one was treated at a non-participating
hospital and another was recruited for knee osteoarthritis but
surgeon treated hip osteoarthritis resulting in the participant
receiving the wrong PtDA/questionnaires.
Primary outcome
The KaplaneMeier estimate of the median time from recruit-
ment to off the wait list across both sites was 16.9 weeks for the
intervention group (n ¼ 165; 95% CI: 15.6, 20.0) and 20.6 weeks for
the control group (n ¼ 163; 95% CI: 17.3, 23.4); wait times for 27 in
the intervention and 32 in the control arms were censored. The
site-speciﬁc medianwait times were 15weeks (95% CI 11.3e16.7) in
intervention vs 18 weeks (95% CI 16.0e20.6) in control at the
community site (Fig. 2), and 27.9 weeks (95% CI 20.9e35.4) in
intervention vs 28.0 weeks (95% CI 19.9e38.0) in control at the
academic site (Fig. 3). The Cox proportional hazards regression
analysis controlling for site and joint yielded HR ¼ 1.25 (95% CI
0.99e1.60, P ¼ 0.0653) (an HR greater than 1 indicates shorter wait
time).
Secondary outcomes
Good decision quality, deﬁned as informed choice that matched
their values, was achieved by 87 (56.1%) in the intervention and 69
(44.5%) in the control groups (RR 1.25; 95% CI: 1.00, 1.56, P ¼ 0.050)
(Table II). Mean total knowledge score for the intervention group
was 12.4 out of 18 (SD 2.79) compared to 11.0 (SD 3.25) control
group (P < 0.001).
Realistic expectations were statistically signiﬁcantly higher for
the intervention compared to control groups for correctly knowing
the proportion of patients post-arthroplasty who would be able towalk with less pain after surgery (79.5%; 67.1%) and have serious
complications from surgery (80.1%; 57.3%) (Table II). Both groups
scored poorly on the number of months for full recovery (9.6%;
5.7%).
Surgery rates were 120 of 164 (73.2%) for intervention and 132
of 164 (80.5%) for control (RR ¼ 0.91; 95% CI: 0.81, 1.03, P ¼ 0.121)
(Table III). Within 2 years, 12 patients in the intervention group
(7.3%) and eight from the control group (4.9%) that chose non-
surgical options returned to the surgical wait list (P ¼ 0.791).
Table III shows changes in patients' preferred treatment option
post-intervention or after seeing the surgeon.
Perceptions of the decision making process. Post-intervention
and before consultation with the surgeon, signiﬁcantly more pa-
tients in the intervention arm than in the control arm felt informed
(93.6% vs 79.6%, P < 0.001) and had clarity about which beneﬁts and
risks mattered most to them (88.5% vs 79.6%, P ¼ 0.044) (Table IV).
Therewere no statistically signiﬁcant differences in the proportions
of patients feeling supported (P ¼ 0.277) or feeling sure about the
best choice (P ¼ 0.235). There were no statistically signiﬁcant dif-
ferences between groups in the proportions of patients achieving 4
out of 4 on the SURE test prior to the surgeon visit (P ¼ 0.347) or
after consultation with the surgeon (6 months) (P ¼ 0.306).
Post-intervention and prior to the consultation, the intervention
compared to control groups were more likely to know that the
decision depended on their values (4.4 vs 4.0 out of 5; P ¼ 0.003)
and felt more prepared to talk to their surgeon about what matters
most to them (4.5 vs 4.1; P ¼ 0.014) (Table V). There were no sta-
tistically signiﬁcant differences between groups for recognizing
that a decision needed to be made or thinking about how involved
they wanted to be in making that decision.
Discussion
Our study sought to examine the effects of a PtDA on appro-
priate and timely access to hip or knee arthroplasty for patients
with osteoarthritis. Controlling for site (academic vs community
hospital) and joint (hip or knee), a non-statistically signiﬁcant trend
was observed whereby the PtDA decreased the time to removal
from the wait list for patients given the PtDA (P-value ¼ 0.0653).
Hence, the PtDA reduced wait times for patients on the surgery
waiting list by removing the patients that do notwant surgery or do
not need surgery as observed in the lower proportion of patients in
the PtDA group electing to have surgery. The effect of the PtDA
varied between the sites: at the community site patients given the
PtDA waited 3 weeks less from screening to deﬁnitive choice;
however, at the academic site, there was no difference in wait
times. The substantial heterogeneity across the sites needs to be
explored. Despite the lack of statistical signiﬁcance in decision
quality, there was a 12% improvement in those exposed to the PtDA
and signiﬁcantly more patients had realistic expectations on two
important outcomes of joint arthroplasty (i.e., pain relief when
walking, serious surgical complications).
This study was conducted in two different clinics that were
established to screen out patients with milder osteoarthritis, and as
expected, most patients in the study hadmore severe osteoarthritis
and were appropriate for considering surgery. Our ﬁndings indicate
a trend in that a higher proportion of patients exposed to the PtDA
achieved decision quality and waited fewer weeks. However, the
PtDA may have greater effect and discrimination aimed at patients
with earlier stages of osteoarthritis and may help them consider
their non-surgical options. When non-surgical therapies have
yielded limited success and pain becomes unmanageable, total
joint arthroplasty is an effective surgical procedure2,28.
In our study, patients who used the PtDA had statistically
signiﬁcantly higher knowledge scores, felt clearer about their
Fig. 1. CONSORT trial ﬂow diagram.
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Table I
Characteristics of participants in each arm
Intervention group (n ¼ 167) Control group (n ¼ 167)
Age (years), mean (SD) 66.1 (9.8) 66.9 (9.8)
Joint Hip 47 45
Knee 120 122
HKPT* (total 80), mean (SD) 45.6 (13.8) 45.5 (13.2)
WOMAC* (total 96), mean (SD) 56.7 (17.3) 53.9 (16.0)
Sex Men 78 64
Women 89 103
BMI, mean (SD) 31.0 (6.5) 31.8 (6.1)
Language English 163 164
Other 4 3
Education Less than high school 11 13
High/technical school 76 70
College 32 24
University 48 60
Living arrangements Alone 39 44
With someone else 128 123
Employment Full time 31 33
Part time 13 18
Retired 105 106
Long term disability 14 5
Unemployed 5 5
Household income <$20,000 14 11
to $39,999 27 35
to $59,999 40 35
to $79,999 34 22
to $99,999 16 16
>$100,000 27 32
no response 9 16
Change in household income Yes 32 19
No 134 145
No response 1 3
Notes: Frequencies, unless otherwise indicated. The typical Canadian income for elderly over 65 years was $58,000 during study recruitment.
HKPT ¼ Hip-Knee Priority Tool; BMI ¼ Body Mass Index.
WOMAC ¼ Western Ontario and McMaster Universities Osteoarthritis Index.
* Higher scores indicate higher severity of osteoarthritis.
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ﬁndings were similar to our pilot study evaluating the PtDA alone
and another study that prepared patients with the same PtDA plus
decision coaching12,14 thereby questioning use of coaching as a
more expensive intervention29. However, a systematic review of 44
studies revealed that patients' capacity to participate in decision
making was most strongly inﬂuenced by lack of knowledge on
options and their preferences, as well as power imbalances30. PtDAsFig. 2. Stratiﬁed KaplaneMeier analysis showing time to removal from wait list at the
community site.have consistently improved knowledge and helped patients clarify
their preferences but little is known about ways to address power
imbalances within the patient-surgeon consultation. Patients have
suggested that nurses could address this power-imbalance by
listening to their preferences and ensuring physicians know their
preferences30. In our study, we used the 1-page preference report
to communicate patients' knowledge and preferences to the sur-
geon together with their osteoarthritis severity.Fig. 3. Stratiﬁed KaplaneMeier analysis showing time to removal from wait list at the
academic site.
Table II
Patients who achieved decision quality, knowledge, and realistic expectations
Intervention n ¼ 156 Control n ¼ 158 P-value
Good decision quality: decision matches features of options that matter most to the informed patient 87 (56.1%) 69 (44.5%) 0.050
Hip-knee decision quality instrument Screener*
Over time, without surgery, what usually happens to the pain from hip (knee) osteoarthritis? 140 (90.3%) 144 (91.1%) 0.803
After hip (knee) replacement surgery, about how many months does it take most people to get back to doing their
usual activities?y
15 (9.6%) 9 (5.7%) 0.191
About how many people who have hip (knee) replacement surgery will need to have the same hip (knee) replaced
again in less than 15 years?
40 (25.6%) 38 (24.2%) 0.769
If 100 people have hip (knee) replacement surgery, about how many will have less hip (knee) pain when walking
after surgery?y
124 (79.5%) 106 (67.1%) 0.013
Out of 100 people who have hip (knee) replacement surgery, about how many will have a serious complication
(e.g., death, life-threatening blood clots, infection, heart attack) within the 3 months after surgery?y
125 (80.1%) 90 (57.3%) <0.001
* Entries are frequency (%) correct answers.
y Questions assessing realistic expectations.
Table III
Patient preferences post-intervention and post-surgical consultation, and actual choice implemented
Patient preferences post-intervention Intervention* (n ¼ 156) Control* (n ¼ 157) P-value
Surgery 105 (67.3) 123 (78.3) 0.063
Non-surgery 21 (13.5) 11 (7.0)
Unsure 30 (19.2) 23 (14.7)
Patient preferences post-surgical consultation (6 months) Intervention (n ¼ 127) Control (n ¼ 127)
Surgery 104 (81.9) 111 (87.4) 0.543
Non-surgery 20 (15.8) 14 (11.0)
Unsure 3 (2.4) 2 (1.6)
Actual choice implemented Intervention (n ¼ 164) Control (n ¼ 164)
Surgery 120 (73.2) 132 (80.5) 0.121
Non-surgery 44 (26.8) 32 (19.5)
* Entries are frequency (%).
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about joint arthroplasty which allowed us to measure whether or
not patients who initially chose non-surgical options subsequently
changed their mind and returned to the surgery wait list. Although
it was not statistically signiﬁcant, we found an initial decrease in
surgical rates in the PtDA group compared to controls (73% vs 81%)
and few patients who subsequently changed their mind to have
surgery in the PtDA group (7%) or control group (5%). Previous trials
indicate that PtDAs can moderate surgical rates by addressing
under-use of surgical procedures that informed patients need and
want, and preventing over-use of procedures that informed pa-
tients do not value11,31. For example, PtDAs reduced preference for
surgery by 21% (e.g., hysterectomy, mastectomy, prostatectomy,
coronary bypass surgery) in regions with high surgical rates in favor
of more conservative options without compromising patient
satisfaction or health outcomes. In regions with low surgical rates
(e.g., prostatectomy in UK), surgery rates increased after patients
were exposed to a PtDA11,32. In our study, the 7% decrease observed
in the intervention compared to the control groups was also likely
inﬂuenced by the pre-surgical screening of patients. A previousTable IV
Decisional conﬂict scores post-intervention and at 6 months (post-surgeon consultation
SURE test items Post-intervention
Intervention n/N (%) Contro
Feels SURE about best choice 110/156 (70.5) 120/1
Knows the beneﬁts and harms of each option 146/156 (93.6) 125/1
Clear about which beneﬁts and risks matter most 138/156 (88.5) 125/1
Has enough support and advice to make choice 133/156 (85.3) 126/1
TOTAL 4 out of 4 104/156 (66.7) 96/15
* Signiﬁcant qualitative interaction by site.study reported that half of patients screened at site 1 were referred
back to primary care because their osteoarthritis did not meet the
surgical appropriateness criteria (e.g., pain and functional limita-
tions interfere with their quality of life despite use of conservative
treatment)8.
A higher proportion of patients reached good decision quality in
the PtDA group compared to controls who received usual education
only. Decision quality is the gold standard measure for determining
PtDA effectiveness21. It is calculated using a composite score that
accounts for being informed (knowledge score) and achieving
values-choice concordance33,34. Values clariﬁcation was measured
by asking patients to rate the 7-items in the Hip-Knee Decision
Quality Instrument on a leaning scale of 1 (not at all important) to
10 (very important). Patients in the intervention group also felt
clearer about their values and better prepared for discussing them
with the surgeon. Using this leaning scale approach to values
clariﬁcation is easier and more transparent for patients compared
to other values clariﬁcation approaches such as conjoint analysis13.
Our decision quality ﬁndings are consistent with our pilot study14
and in the same direction as the meta-analysis in the Cochrane)
6 months Post-surgeon
l n/N (%) P-value Intervention n/N (%) Control n/N (%) P-value
57 (76.4) 0.235 115/126 (91.3) 115/127 (90.6) 0.846
57 (79.6) <0.001 122/126 (96.8) 116/127 (92.1) 0.101
57 (79.6) 0.044 121/126 (96.0) 118/127 (93.7) 0.396
57 (80.3) 0.277* 120/126 (95.2) 118/127 (92.9) 0.438
7 (61.2) 0.347 109/126 (86.5) 103/127 (81.8) 0.306
Table V
Feeling prepared for decision making post-intervention (pre-surgeon consult)
Preparation for Decision Making Scale Items* (Mean, SD) Intervention n ¼ 156 Control n ¼ 157 P-value
Help recognize decision to be made 4.16 (1.01) 3.91 (1.17) 0.070
Help know decision depends on what matters most 4.40 (0.84) 4.03 (1.14) 0.003
Help think about how involved you want to be in decision 4.40 (0.88) 4.27 (1.05) 0.426
Prepare to talk to your doctor about what matters most 4.47 (0.68) 4.10 (1.14) 0.014
* Scored on a 5-point scale from 1 (not at all) to 5 (a great deal).
D. Stacey et al. / Osteoarthritis and Cartilage 24 (2016) 99e107106review of PtDA trials that showed a 51% improvement in informed
values-based choices using various measures11.
Our study addresses concerns that a previous trial did not reﬂect
usual practice or include typical patients35. For our study, patient
recruitment occurred in a pre-surgical screening clinic that is usual
practice for referral to orthopedic specialists in our community. Our
eligibility criteria were inclusive. As a result, half of our participants
had high school education or less and half had household incomes
at or below the median income ($58,000) for couples aged 65 or
older in Canada. Although the video feature of the PtDA we used
made it easier to reach individuals with lower education and lower
health literacy36, we did not assess participants' health literacy.
Limitations
Several limitations must be considered when interpreting the
results of this trial. There was potential for self-report bias given
that decision quality components, decisional conﬂict, and prepa-
ration for decisionmaking are all patient reported. However, for the
primary outcome of wait times, patient reported data was trian-
gulated with data from the clinic records. Although we provided
surgeons with a patient preference report summarizing patients'
clinical data together with their knowledge, values for outcomes of
options, and preferences, we did not measure if surgeons looked at
the report or its inﬂuence on the consultation. Finally, this was a
pragmatic trial in that we did not aim to standardize the usual
clinical ﬂow across sites but rather evaluated the effectiveness of
the PtDA within two sites. However, accounting for two sites
increased variability in the ﬁndings.
Conclusions
Using PtDAs for patients with osteoarthritis considering hip or
knee arthroplasty appears to have optimized the surgical referral by
enhancing patients' knowledge, ensuring realistic expectations of
outcomes of options, and helping patients be clear about what
matters most. However, despite having a trend towards shorter
wait time in the PtDA group, this was observed at only one site and
the overall effect was not statistically signiﬁcant. Further research is
required to measure the effect of PtDAs with the one-page prefer-
ence report for surgeons on shared decision making within the
consultation.
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